Amarin Corp Plc (AMRN)

[KCSVEN]

I like how they throw this into the Reduce IT press release..


"An SPA agreement is generally considered binding upon the FDA unless public health concerns unrecognized at the time of protocol assessment are evident."

So why is it they could back out of Anchor approval?

Though I'm also not 100% convinced WS thinks Anchor has any chance of denial, sure minor overhang but think WS is more concerned with how AMRN will s ell Anchor, partner or dilution and GIA? So in the long run I expect they can get sales to a profitable level, I do believe the biggest overhang is lack of clarification for Anchor launch, not actual Anchor approval.

Then the overhang if GIA will be how are they going to raise money GIA to launch.